SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-16-028420
Filing Date
2016-03-25
Accepted
2016-03-25 15:09:02
Documents
5
Period of Report
2016-01-08
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A dffn20160316_8ka.htm 8-K/A 40877
2 EXHIBIT 16.2 ex16-2.htm EX-16.2 4920
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 5027
4 EXHIBIT 99.3 ex99-3.htm EX-99.3 506902
5 EXHIBIT 99.4 ex99-4.htm EX-99.4 240681
  Complete submission text file 0001437749-16-028420.txt   799853
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-24477 | Film No.: 161529572
SIC: 2834 Pharmaceutical Preparations